BVXV innovative COVID-19 nanosized antibodies
BiondVax has signed definitive agreements with the Max Planck Society and the University Medical Center Göttingen to enter into a strategic collaboration for the development and commercialization of innovative COVID-19 nanosized antibodies (NanoAbs).
NanoAbs exhibited in-vitro neutralization of all COVID-19 variants of concern including Delta, and based on in-silico studies, Omicron, at significantly lower dose levels than existing antibody treatments.
i know that this is an early stage, but today they announced also that the Former CFO of GSK's Global Vaccines Business Mr. Jay Green Joins BiondVax's Board of Directors.
just to make an idea, GSK has a Market Cap of 111Bil and Jay Green went to a company that has a mk cap of 35Mil.
They also had a public offering at the price of $2.36.
52 Week Range 1.36 - 7.22
My price target is $6
NanoAbs exhibited in-vitro neutralization of all COVID-19 variants of concern including Delta, and based on in-silico studies, Omicron, at significantly lower dose levels than existing antibody treatments.
i know that this is an early stage, but today they announced also that the Former CFO of GSK's Global Vaccines Business Mr. Jay Green Joins BiondVax's Board of Directors.
just to make an idea, GSK has a Market Cap of 111Bil and Jay Green went to a company that has a mk cap of 35Mil.
They also had a public offering at the price of $2.36.
52 Week Range 1.36 - 7.22
My price target is $6
BUYSELL indicators tradingindicators.store/
TRADING COURSE bit.ly/tradex
Private Signals patreon.com/PremiumOptionsSignals
RESULTS bit.ly/topgx
1%/DAY: bit.ly/3F56VTW
BYBIT partner.bybit.com/b/37880
TRADING COURSE bit.ly/tradex
Private Signals patreon.com/PremiumOptionsSignals
RESULTS bit.ly/topgx
1%/DAY: bit.ly/3F56VTW
BYBIT partner.bybit.com/b/37880
Clause de non-responsabilité
Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.